388 related articles for article (PubMed ID: 19929825)
1. Two-dimensional (2D) in silico models for absorption, distribution, metabolism, excretion and toxicity (ADME/T) in drug discovery.
Khakar PS
Curr Top Med Chem; 2010; 10(1):116-26. PubMed ID: 19929825
[TBL] [Abstract][Full Text] [Related]
2. In silico ADME-Tox modeling: progress and prospects.
Alqahtani S
Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1147-1158. PubMed ID: 28988506
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic properties and in silico ADME modeling in drug discovery.
Honório KM; Moda TL; Andricopulo AD
Med Chem; 2013 Mar; 9(2):163-76. PubMed ID: 23016542
[TBL] [Abstract][Full Text] [Related]
4. In Silico Absorption, Distribution, Metabolism, Excretion, and Pharmacokinetics (ADME-PK): Utility and Best Practices. An Industry Perspective from the International Consortium for Innovation through Quality in Pharmaceutical Development.
Lombardo F; Desai PV; Arimoto R; Desino KE; Fischer H; Keefer CE; Petersson C; Winiwarter S; Broccatelli F
J Med Chem; 2017 Nov; 60(22):9097-9113. PubMed ID: 28609624
[TBL] [Abstract][Full Text] [Related]
5. Structure-ADME relationship: still a long way to go?
Hou T; Wang J
Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):759-70. PubMed ID: 18611116
[TBL] [Abstract][Full Text] [Related]
6. Predicting ADME properties and side effects: the BioPrint approach.
Krejsa CM; Horvath D; Rogalski SL; Penzotti JE; Mao B; Barbosa F; Migeon JC
Curr Opin Drug Discov Devel; 2003 Jul; 6(4):470-80. PubMed ID: 12951810
[TBL] [Abstract][Full Text] [Related]
7. In silico ADME prediction: data, models, facts and myths.
Lombardo F; Gifford E; Shalaeva MY
Mini Rev Med Chem; 2003 Dec; 3(8):861-75. PubMed ID: 14529504
[TBL] [Abstract][Full Text] [Related]
8. In silico prediction of cytochrome P450-mediated drug metabolism.
Zhang T; Chen Q; Li L; Liu LA; Wei DQ
Comb Chem High Throughput Screen; 2011 Jun; 14(5):388-95. PubMed ID: 21470181
[TBL] [Abstract][Full Text] [Related]
9. In silico predictions of ADME/T properties: progress and challenge.
Hou T
Comb Chem High Throughput Screen; 2011 Jun; 14(5):306. PubMed ID: 21470177
[No Abstract] [Full Text] [Related]
10. Improving early drug discovery through ADME modelling: an overview.
Wishart DS
Drugs R D; 2007; 8(6):349-62. PubMed ID: 17963426
[TBL] [Abstract][Full Text] [Related]
11. Progress in predicting human ADME parameters in silico.
Ekins S; Waller CL; Swaan PW; Cruciani G; Wrighton SA; Wikel JH
J Pharmacol Toxicol Methods; 2000; 44(1):251-72. PubMed ID: 11274894
[TBL] [Abstract][Full Text] [Related]
12. In-silico ADME models: a general assessment of their utility in drug discovery applications.
Gleeson MP; Hersey A; Hannongbua S
Curr Top Med Chem; 2011; 11(4):358-81. PubMed ID: 21320065
[TBL] [Abstract][Full Text] [Related]
13. In silico approaches for predicting ADME properties of drugs.
Yamashita F; Hashida M
Drug Metab Pharmacokinet; 2004 Oct; 19(5):327-38. PubMed ID: 15548844
[TBL] [Abstract][Full Text] [Related]
14. In silico ADME/T modelling for rational drug design.
Wang Y; Xing J; Xu Y; Zhou N; Peng J; Xiong Z; Liu X; Luo X; Luo C; Chen K; Zheng M; Jiang H
Q Rev Biophys; 2015 Nov; 48(4):488-515. PubMed ID: 26328949
[TBL] [Abstract][Full Text] [Related]
15. High-throughput and in silico techniques in drug metabolism and pharmacokinetics.
van de Waterbeemd H
Curr Opin Drug Discov Devel; 2002 Jan; 5(1):33-43. PubMed ID: 11865671
[TBL] [Abstract][Full Text] [Related]
16. Troubleshooting computational methods in drug discovery.
Kortagere S; Ekins S
J Pharmacol Toxicol Methods; 2010; 61(2):67-75. PubMed ID: 20176118
[TBL] [Abstract][Full Text] [Related]
17. The use of machine learning and nonlinear statistical tools for ADME prediction.
Sakiyama Y
Expert Opin Drug Metab Toxicol; 2009 Feb; 5(2):149-69. PubMed ID: 19239395
[TBL] [Abstract][Full Text] [Related]
18. Systematic Evaluation of Local and Global Machine Learning Models for the Prediction of ADME Properties.
Di Lascio E; Gerebtzoff G; Rodríguez-Pérez R
Mol Pharm; 2023 Mar; 20(3):1758-1767. PubMed ID: 36745394
[TBL] [Abstract][Full Text] [Related]
19. Artificial intelligence in drug design.
Zhong F; Xing J; Li X; Liu X; Fu Z; Xiong Z; Lu D; Wu X; Zhao J; Tan X; Li F; Luo X; Li Z; Chen K; Zheng M; Jiang H
Sci China Life Sci; 2018 Oct; 61(10):1191-1204. PubMed ID: 30054833
[TBL] [Abstract][Full Text] [Related]
20. High throughput ADME screening: practical considerations, impact on the portfolio and enabler of in silico ADME models.
Hop CE; Cole MJ; Davidson RE; Duignan DB; Federico J; Janiszewski JS; Jenkins K; Krueger S; Lebowitz R; Liston TE; Mitchell W; Snyder M; Steyn SJ; Soglia JR; Taylor C; Troutman MD; Umland J; West M; Whalen KM; Zelesky V; Zhao SX
Curr Drug Metab; 2008 Nov; 9(9):847-53. PubMed ID: 18991580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
